US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SANUWAVE Health, Inc.

31.37

+1.675.62%

Volume:8.04K

Turnover:247.42K

Market Cap:268.39M

PE:-5.62

High:31.38

Open:30.05

Low:30.05

Close:29.70

Loading ...

Overview Company News Filings

Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares

Sanuwave Health Inc. Appoints Industry Veteran Dustin Libby as Executive VP of Commercial Operations

SANUWAVE Health Inc. Files Initial Beneficial Ownership Statement for Director Gregory Matthew Bazar

SANUWAVE Health Inc. Joins Russell 2000® Index

SANUWAVE Health Inc. Appoints Greg Bazar to Board of Directors as Michael Stolarski Steps Down

Sanuwave Health Appoints Greg Bazar to Board of Directors

THOMSON REUTERS

Iulian Cioanta, Chief Scientific and Technology Officer, Reports Disposal of Common Shares in SANUWAVE Health Inc

SANUWAVE Health Inc. Changes Auditors Amid Internal Control Weaknesses

Sanuwave Announces Q1 FY2025 Financial Results

THOMSON REUTERS

Sanuwave Health Inc - Forecasts 40-50% Revenue Growth for Q2 2025

THOMSON REUTERS

SANUWAVE Health Q1 EPS $(0.66) Up From $(1.46) YoY, Sales $9.34M Up From $5.79M YoY

Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results

Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025

Sanuwave Health : Does Not Anticipate Any Significant Effects on Production From Current Tariff Situation

THOMSON REUTERS

Sanuwave Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

THOMSON REUTERS

Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

Sanuwave Health Shares Rise on 2025 Outlook

SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY

Sanuwave Health Inc: Outlook 2025 Revenue Guidance of $48 Mln - 50 Mln

THOMSON REUTERS

Sanuwave Announces Record Quarterly Revenues: Q4 FY2024 Financial Results

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SNWV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SNWV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","market":"US","secType":"STK","nameCN":"SANUWAVE Health, Inc.","latestPrice":31.37,"timestamp":1750086723467,"preClose":29.7,"halted":0,"volume":8042,"delay":0,"floatShares":4799891,"shares":8555616,"eps":-5.582863,"marketStatus":"Trading","change":1.67,"latestTime":"06-16 11:12:49 EDT","open":30.05,"high":31.38,"low":30.05,"amount":247418.40276,"amplitude":0.044781,"askPrice":31.34,"askSize":258,"bidPrice":31.14,"bidSize":127,"shortable":3,"etf":0,"ttmEps":-5.582863,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1750104000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":29.7,"postHourTrading":{"tag":"盘后","latestPrice":29.7,"preClose":29.7,"latestTime":"16:04 EDT","volume":189,"amount":5613.3,"timestamp":1749845043916},"volumeRatio":0.510071},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","floatShares":4799891,"roa":"17.20%","roe":"196.48%","lyrEps":-7.029536,"volumeRatio":0.510071,"shares":8555616,"dividePrice":0,"high":31.38,"amplitude":0.044781,"preClose":29.7,"low":30.05,"week52Low":5.1743,"pbRate":"-15.52","psRate":"7.42","week52High":39.5,"institutionHeld":0,"latestPrice":31.37,"committee":-0.34026,"eps":-5.582863,"divideRate":0,"volume":8042,"delay":0,"ttmEps":-5.582863,"open":30.05,"prevYearClose":23,"prevWeekClose":29.7,"prevMonthClose":26.2,"prevQuarterClose":35.37,"fiveDayClose":30.16,"twentyDayClose":32.31,"sixtyDayClose":32},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNWV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2542563263","title":"Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2542563263","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542563263?lang=en_us&edition=fundamental","pubTime":"2025-06-10 07:51","pubTimestamp":1749513072,"startTime":"0","endTime":"0","summary":"Peter Stegagno, Chief Operating Officer of SANUWAVE Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250609:nNDL4NCvLF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Chief Operating Officer Peter Stegagno Reports Disposal of SANUWAVE Health Inc. Common Shares","news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2540769487","title":"Sanuwave Health Inc. Appoints Industry Veteran Dustin Libby as Executive VP of Commercial Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2540769487","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540769487?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:30","pubTimestamp":1748950245,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has appointed Dustin Libby as the new Executive Vice President of Commercial Operations. Libby, who started on June 3, 2025, brings 20 years of experience in medical devices, with a focus on commercial growth and sales operations. His previous roles include leadership positions at Abiomed, Smith & Nephew, Arthrex, and Hill-ROM. Libby holds a B.S. degree in Product Design & Development from Keene State College.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on June 03, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nNDL1gHPLs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703251.USD","IE00B1BXHZ80.USD","LU0058720904.USD","IE00B3PB1722.GBP","LU2129689514.USD","IE0002141913.USD","LU0098860793.USD","LU0882574055.USD","LU1674673691.USD","LU1280957306.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","IE00B19Z3581.USD","LU0289739699.SGD","SNWV","IE00B42XCP33.USD","LU0345770308.USD","SG9999002224.SGD","IE00BKPKM429.USD","BK4588","LU2129689431.USD","LU0345769631.USD","IE00B3T34201.USD","LU2112291526.USD","LU1066053197.SGD","LU0795875086.SGD","IE00BDGV0183.EUR","IE0034235303.USD","LU1032466523.USD","IE00BGHQF748.EUR","LU1061106388.HKD","IE00BFTCPJ56.SGD","LU0203345920.USD","IE00B2B36J28.USD","LU1023059063.AUD","IE00BVYPNW00.USD","LU1221951129.SGD","LU1244550577.SGD","LU1074936037.SGD","LU1894683348.USD","BK4592","LU1914381329.SGD","LU1244550221.USD","NDAQ","LU1732800096.USD","LU1778281490.HKD","JNJ","LU2602419157.SGD","BK4532","BK4007"],"gpt_icon":0},{"id":"2539295481","title":"SANUWAVE Health Inc. Files Initial Beneficial Ownership Statement for Director Gregory Matthew Bazar","url":"https://stock-news.laohu8.com/highlight/detail?id=2539295481","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539295481?lang=en_us&edition=fundamental","pubTime":"2025-05-30 04:26","pubTimestamp":1748550369,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Gregory Matthew Bazar as a director of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250529:nNDL2dbt7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2539098774","title":"SANUWAVE Health Inc. Joins Russell 2000® Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2539098774","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539098774?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:10","pubTimestamp":1748463010,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. is going to be added to the Russell 2000 Index as part of the 2025 Russell indexes reconstitution. This inclusion is based on the company's market-capitalization ranking, as the annual reconstitution process captures the 4,000 largest U.S. stocks.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDLb9C3Zg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4082","BK4588","IE00BGHQF748.EUR","SNWV","LU2210150020.SGD","IE00B64PRP62.GBP","BK4585","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","NDAQ","LU2210149790.SGD"],"gpt_icon":0},{"id":"2539067274","title":"SANUWAVE Health Inc. Appoints Greg Bazar to Board of Directors as Michael Stolarski Steps Down","url":"https://stock-news.laohu8.com/highlight/detail?id=2539067274","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539067274?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:05","pubTimestamp":1748462733,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc. has appointed Greg Bazar to its Board of Directors, effective May 27, 2025. Bazar brings extensive experience in engineering, technology, and cybersecurity. Concurrently, long-time board member Michael Stolarski will be stepping down but will continue as a consultant to assist in the transition.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via GlobeNewswire  on May 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nNDL58M1ts:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","NDAQ"],"gpt_icon":0},{"id":"2539793406","title":"Sanuwave Health Appoints Greg Bazar to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2539793406","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539793406?lang=en_us&edition=fundamental","pubTime":"2025-05-29 04:05","pubTimestamp":1748462700,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250528:nTUA3RGYC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2536323689","title":"Iulian Cioanta, Chief Scientific and Technology Officer, Reports Disposal of Common Shares in SANUWAVE Health Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2536323689","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536323689?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:49","pubTimestamp":1747428542,"startTime":"0","endTime":"0","summary":"Iulian Cioanta, Chief Scientific and Technology Officer of SANUWAVE Health Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SANUWAVE Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 16, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDLQYPDZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2535870289","title":"SANUWAVE Health Inc. Changes Auditors Amid Internal Control Weaknesses","url":"https://stock-news.laohu8.com/highlight/detail?id=2535870289","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535870289?lang=en_us&edition=fundamental","pubTime":"2025-05-16 04:17","pubTimestamp":1747340225,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Inc., a Nevada corporation, announced a change in its independent registered public accounting firm, transitioning from CBIZ CPAs P.C. to Baker Tilly US, LLP, effective for the fiscal year ending December 31, 2025. The decision, approved by the company's Audit Committee, comes after identifying material weaknesses in internal controls over financial reporting. These weaknesses include a lack of internal controls over key accounting and IT processes, insufficient expertise to apply U.S. GAAP to complex transactions, and inadequate resources for financial instrument accounting in service agreements. The transition aims to address these issues and enhance the company's financial reporting standards.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, inves","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDL4K9SY3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2534617774","title":"Sanuwave Announces Q1 FY2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2534617774","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534617774?lang=en_us&edition=fundamental","pubTime":"2025-05-09 18:00","pubTimestamp":1746784801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA154JZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2534517704","title":"Sanuwave Health Inc - Forecasts 40-50% Revenue Growth for Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2534517704","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534517704?lang=en_us&edition=fundamental","pubTime":"2025-05-09 18:00","pubTimestamp":1746784801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nTUA154JZF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2534162365","title":"SANUWAVE Health Q1 EPS $(0.66) Up From $(1.46) YoY, Sales $9.34M Up From $5.79M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2534162365","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534162365?lang=en_us&edition=fundamental","pubTime":"2025-05-09 04:47","pubTimestamp":1746737231,"startTime":"0","endTime":"0","summary":"SANUWAVE Health (OTC:SNWV) reported quarterly losses of $(0.66) per share. This is a 54.79 percent increase over losses of $(1.46) per share from the same period last year.  The company reported $9.34 million in sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45302153/sanuwave-health-q1-eps-0-66-up-from-1-46-yoy-sales-9-34m-up-from-5-79m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2533056502","title":"Sanuwave Will Host a Conference Call on May 9, 2025 at 8:30 AM (ET) to Present Q1 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2533056502","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533056502?lang=en_us&edition=fundamental","pubTime":"2025-05-06 05:00","pubTimestamp":1746478800,"startTime":"0","endTime":"0","summary":"EDEN PRAIRIE, Minn., May 05, 2025  -- Sanuwave Health, Inc.  , a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 9, 2025, at 8:30 AM  to present its Q1 2025 financial results.Telephone access to the call will be available by dialing the following numbers:. Sanuwave Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanuwave-host-conference-call-may-210000136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4561","AM","BK4588","BK4181","BK4082","HST","SNWV","BK4581","ET","BK4218","BK4144","BK4585","BK4590"],"gpt_icon":0},{"id":"2525481846","title":"Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525481846","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525481846?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:45","pubTimestamp":1744119934,"startTime":"0","endTime":"0","summary":"April 8 (Reuters) - SANUWAVE Health Inc ::*SANUWAVE HEALTH ANNOUNCES PRELIMINARY REVENUE RESULTS FOR THE FIRST QUARTER 2025 (ENDED MARCH 31, 2025)*SANUWAVE HEALTH : DOES NOT ANTICIPATE ANY SIGNIFICANT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nRSD4SpDml:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWVD","SNWV"],"gpt_icon":0},{"id":"2525891756","title":"Sanuwave Health : Does Not Anticipate Any Significant Effects on Production From Current Tariff Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891756?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA6NHNHL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2525891206","title":"Sanuwave Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891206?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA6NHNHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2525891216","title":"Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891216?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115400,"startTime":"0","endTime":"0","summary":"SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history.Q1 2025 revenue increased between 57% and 61% compared to Q1 2024.UltraMIST revenues for Q1 2025 increased by more than 65% versus Q1 2024 and accounted for approximately 99% of the Company's total revenues.\"Sanuwave is pleased to announce a strong start to 2025, putting up our best Q1 in Company history,\" said CEO Morgan Frank. \"Q1 was a transition quarter as we moved to a new head of sales and restructured the sales force. I'm very proud of the team managing this without missing a beat. Our pipeline remains robust and consistent with 2025 being a breakout year for Sanuwave. The Company plans to release its full Q1 results on or around May 9, 2025 and we look forward to speaking with you then to give you a more complete update on our quarterly performance and our future plans and guidance.\"","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2521557202","title":"Sanuwave Health Shares Rise on 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2521557202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521557202?lang=en_us&edition=fundamental","pubTime":"2025-03-22 03:05","pubTimestamp":1742583900,"startTime":"0","endTime":"0","summary":"Shares of Sanuwave Health climbed on the path toward their highest close in almost three years after the company guided for further growth in 2025.The stock gained 13%, to $36.20, in Friday afternoon trading. Shares are up 57% year to date.The developer of patented noninvasive, biological response activating devices said it expects revenue of $48 million to $50 million for 2025 as it guided for a first-quarter top-line performance between $8.4 million and $9 million.In 2024, the company had reported revenue of $32.6 million.\"We are confident that our revenue pipeline is stronger than it has ever been and have been ramping up our sales force and sales strategy to meet this opportunity and to effectively manage the larger customers with whom we continue to engage,\" Chief Executive Morgan Frank said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2521640309","title":"SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2521640309","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521640309?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:05","pubTimestamp":1742551536,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44432262/sanuwave-health-q4-sales-10-326m-up-from-6-994m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2521840349","title":"Sanuwave Health Inc: Outlook 2025 Revenue Guidance of $48 Mln - 50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521840349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521840349?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2521408080","title":"Sanuwave Announces Record Quarterly Revenues: Q4 FY2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521408080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521408080?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNWV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"SNWV","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":-0.66},{"date":"2025-04-08","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1744099200000,"name":null,"time":"Pre-Market","dateTimestamp":1744084800000,"actualEps":null},{"date":"2025-03-21","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1742544000000,"name":null,"time":"Pre-Market","dateTimestamp":1742529600000,"actualEps":null},{"market":"US","date":"2024-11-08","symbol":"SNWV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-10-18","symbol":"SNWV","defaultRemindTime":1729258200000,"type":"split","dateTimestamp":1729224000000,"forFactor":7874,"toFactor":21,"ratio":374.95238095238096}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNWV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNWV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNWV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNWV","date":"2025-06-13","current":-8.153092,"percent":0.544118,"low":-702.038129,"twenty":-10.259149,"median":-8.223668,"eighty":-7.613389,"high":-6.892901,"avg":-111.150254,"sd":236.815113,"marketCap":265138539},"quantilePoints":[{"date":"2025-03-07","current":-691.068781,"twenty":-691.068781,"median":-691.068781,"eighty":-691.068781,"marketCap":268825756},{"date":"2025-03-14","current":-618.012938,"twenty":-636.222054,"median":-618.342019,"eighty":-603.314015,"marketCap":240407033},{"date":"2025-03-21","current":-702.038129,"twenty":-696.553455,"median":-636.222054,"eighty":-618.012938,"marketCap":273092832},{"date":"2025-03-28","current":-10.158328,"twenty":-695.675907,"median":-618.342019,"eighty":-10.354519,"marketCap":318687073},{"date":"2025-04-04","current":-8.120123,"twenty":-691.068781,"median":-601.668614,"eighty":-10.158328,"marketCap":254744495},{"date":"2025-04-11","current":-7.981154,"twenty":-636.222054,"median":-10.315009,"eighty":-8.485256,"marketCap":250384774},{"date":"2025-04-17","current":-7.964805,"twenty":-631.834315,"median":-10.235987,"eighty":-8.284706,"marketCap":249871865},{"date":"2025-04-25","current":-8.106499,"twenty":-621.084356,"median":-9.959412,"eighty":-8.117398,"marketCap":254317071},{"date":"2025-05-02","current":-7.937556,"twenty":-618.14457,"median":-8.840852,"eighty":-7.959355,"marketCap":249017018},{"date":"2025-05-09","current":-8.596976,"twenty":-606.2538,"median":-8.485256,"eighty":-7.977884,"marketCap":269704323},{"date":"2025-05-16","current":-8.230402,"twenty":-601.997694,"median":-8.460732,"eighty":-7.977884,"marketCap":267652689},{"date":"2025-05-23","current":-7.589004,"twenty":-128.772111,"median":-8.419859,"eighty":-7.932511,"marketCap":246794415},{"date":"2025-05-30","current":-7.413815,"twenty":-10.431905,"median":-8.357187,"eighty":-7.77174,"marketCap":241097258},{"date":"2025-06-06","current":-7.313841,"twenty":-10.307106,"median":-8.265183,"eighty":-7.613389,"marketCap":237846124},{"date":"2025-06-13","current":-8.153092,"twenty":-10.259149,"median":-8.223668,"eighty":-7.613389,"marketCap":265138539}],"updateTime":1750086646139}}}